Dyne Therapeutics Inc. (DYN)
12.04
-0.32 (-2.59%)
At close: Mar 13, 2025, 11:44 AM
Dyne Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Net Income | -317.42M | -235.94M | -168.1M | -149.29M | -59.44M | -14.86M | -4.81M | 76M | -1.24B | 50M | -67M | -356M | 87M | -1.65B | -234M | -1.26B | 174M | 264M |
| Depreciation & Amortization | -1.93M | 571K | 1.68M | 1.09M | 700K | 271K | 24K | 867M | 766M | 614M | 292M | 467M | 26M | 346M | 408M | 359M | 376M | 333M |
| Stock-Based Compensation | 45.86M | 19.97M | 15.18M | 17.54M | 6.59M | 26K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -10.54M | 3.34M | -4.14M | -4.45M | -3.46M | -284K | -34K | -1.71B | 658M | -767M | 1.02B | 248M | 696M | -317M | 506M | -871M | 437M | 142M |
| Other Non-Cash Items | 607K | 929K | 2.97M | -746K | 514K | 1.32M | 21K | 584M | 136M | -215M | -1.34B | -275M | -340M | 813M | -434M | 2.38B | -741M | -471M |
| Deferred Income Tax | n/a | n/a | n/a | 2.59M | 12K | n/a | n/a | 610M | 45M | 477M | 1M | 56M | n/a | 632M | 195M | -436M | 73M | 215M |
| Change in Working Capital | -19.49M | 26.31M | -5.38M | 9.26M | 5.11M | 1.41M | 601K | -1.6B | 938M | -860M | 1.03B | 268M | 183M | -166M | 488M | -910M | 437M | 522M |
| Operating Cash Flow | -292.37M | -188.16M | -153.65M | -119.56M | -46.51M | -11.83M | -4.16M | 585M | 676M | 94M | -62M | 175M | -44M | -20M | 423M | 135M | 319M | 341M |
| Capital Expenditures | -2.38M | -729K | -3.07M | -3.62M | -1.16M | -1.65M | -134K | -224M | -326M | -275M | n/a | -98M | n/a | -242M | -333M | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | 34K | 8K | n/a | n/a | n/a | -3.32B | n/a | -6.08B | n/a | 234M | n/a | n/a | n/a | n/a | n/a | -128M |
| Purchase of Investments | -317.44M | -44.26M | -121.18M | -236.72M | -44.5M | n/a | n/a | n/a | n/a | -250M | n/a | n/a | n/a | n/a | -508M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 115.71M | 128.3M | 211.44M | 102.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 35K | 1.00 | -34K | -8K | -44.5M | n/a | n/a | 784M | -1.82B | 5.41B | -5.15B | 338M | 348M | -12M | 307M | 251M | -102M | -689M |
| Investing Cash Flow | -204.08M | 83.31M | 87.2M | -137.89M | -45.66M | -1.65M | -134K | -2.76B | -2.15B | -1.19B | -5.15B | 474M | 348M | -254M | -534M | 251M | -102M | -817M |
| Debt Repayment | n/a | n/a | n/a | n/a | -64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -250M | -1.87B | -843M | -348M | -396M | -291M | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 36.84M | 3.91M | 529K | 584K | 134.37M | 19.99M | 12.41M | -1.3B | 2.74B | -265M | 5.21B | -154M | -328M | 379M | -69M | -608M | 148M | 433M |
| Financial Cash Flow | 809.89M | 54.32M | 37.39M | 157.82M | 380.69M | 19.99M | 12.42M | -1.3B | 2.74B | -265M | 5.21B | -154M | -328M | 379M | -69M | -608M | 148M | 433M |
| Net Cash Flow | 313.45M | -50.52M | -29.05M | -99.63M | 288.52M | 6.51M | 12.42M | -3.47B | 1.27B | -1.36B | n/a | 495M | -107M | 105M | -180M | -222M | 365M | -43M |
| Free Cash Flow | -294.75M | -188.89M | -156.71M | -123.18M | -47.67M | -13.48M | -4.3M | 361M | 350M | -181M | -62M | 77M | -44M | -262M | 90M | 135M | 319M | 341M |